社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
miaomee
IP属地：未知
+关注
帖子 · 267
帖子 · 267
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
miaomee
miaomee
·
2021-12-28
Comment n like
Novavax Shares Jumped 3% in Morning Trading<blockquote>Novavax 股价早盘上涨 3%</blockquote>
Novavax shares jumped 3% in morning trading.The stock plunged nearly 11% yesterday.
Novavax Shares Jumped 3% in Morning Trading<blockquote>Novavax 股价早盘上涨 3%</blockquote>
看
3,469
回复
2
点赞
8
编组 21备份 2
分享
举报
miaomee
miaomee
·
2021-12-24
Like n comment pls
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?<blockquote>辉瑞的口服 COVID-19 药丸能带来多少收入？</blockquote>
Pfizer, Inc. announced Wednesday its oral COVID-19 antiviral pill, Paxlovid, has been authorized for
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?<blockquote>辉瑞的口服 COVID-19 药丸能带来多少收入？</blockquote>
看
3,095
回复
2
点赞
4
编组 21备份 2
分享
举报
miaomee
miaomee
·
2021-12-23
Like n comment
非常抱歉，此主贴已删除
看
3,360
回复
1
点赞
3
编组 21备份 2
分享
举报
miaomee
miaomee
·
2021-12-21
Comment
非常抱歉，此主贴已删除
看
3,933
回复
1
点赞
4
编组 21备份 2
分享
举报
miaomee
miaomee
·
2021-12-21
Nice
Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.<blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote>
Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%. Pfizer
Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.<blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote>
看
3,836
回复
2
点赞
3
编组 21备份 2
分享
举报
miaomee
miaomee
·
2021-12-20
Like n comment pls
非常抱歉，此主贴已删除
看
3,480
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
miaomee
miaomee
·
2021-12-08
Comment n like pls
New Street Research raised Tesla's target price to $1580, the highest price on Wall Street<blockquote>新街研究将特斯拉目标价上调至1580美元，为华尔街最高价</blockquote>
Tesla shares changed from decline to rise in premarket trading after New Street Research raised Tesl
New Street Research raised Tesla's target price to $1580, the highest price on Wall Street<blockquote>新街研究将特斯拉目标价上调至1580美元，为华尔街最高价</blockquote>
看
3,580
回复
2
点赞
6
编组 21备份 2
分享
举报
miaomee
miaomee
·
2021-12-08
Wow
New Street Research raised Tesla's target price to $1580, the highest price on Wall Street<blockquote>新街研究将特斯拉目标价上调至1580美元，为华尔街最高价</blockquote>
Tesla shares changed from decline to rise in premarket trading after New Street Research raised Tesl
New Street Research raised Tesla's target price to $1580, the highest price on Wall Street<blockquote>新街研究将特斯拉目标价上调至1580美元，为华尔街最高价</blockquote>
看
3,424
回复
评论
点赞
3
编组 21备份 2
分享
举报
miaomee
miaomee
·
2021-12-06
Like n comment pls
Apple stock surged more than 3% in morning trading<blockquote>苹果股价早盘飙升超过 3%</blockquote>
Apple stock surged more than 3% in morning trading.Apple plans to produce up to 96 million iPhones f
Apple stock surged more than 3% in morning trading<blockquote>苹果股价早盘飙升超过 3%</blockquote>
看
3,355
回复
2
点赞
6
编组 21备份 2
分享
举报
miaomee
miaomee
·
2021-12-06
Comment n like pls
Semiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote>
Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Se
Semiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote>
看
3,422
回复
4
点赞
8
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3569375896365334","uuid":"3569375896365334","gmtCreate":1606294459318,"gmtModify":1621085770636,"name":"miaomee","pinyin":"miaomee","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":36,"headSize":402,"tweetSize":267,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.05.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":696223088,"gmtCreate":1640706454734,"gmtModify":1640706455124,"author":{"id":"3569375896365334","authorId":"3569375896365334","name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569375896365334","authorIdStr":"3569375896365334"},"themes":[],"title":"","htmlText":"Comment n like ","listText":"Comment n like ","text":"Comment n like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696223088","repostId":"1150918555","repostType":4,"repost":{"id":"1150918555","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640702663,"share":"https://www.laohunote.com/m/news/1150918555?lang=zh_CN&edition=full","pubTime":"2021-12-28 22:44","market":"us","language":"en","title":"Novavax Shares Jumped 3% in Morning Trading<blockquote>Novavax 股价早盘上涨 3%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1150918555","media":"Tiger Newspress","summary":"Novavax shares jumped 3% in morning trading.The stock plunged nearly 11% yesterday.","content":"<p>Novavax shares jumped 3% in morning trading.The stock plunged nearly 11% yesterday.</p><p><blockquote>Novavax 股价在早盘交易中上涨 3%。该股昨天暴跌近11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d7f50d71385e7262972c51f222a641a6\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Shares Jumped 3% in Morning Trading<blockquote>Novavax 股价早盘上涨 3%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Shares Jumped 3% in Morning Trading<blockquote>Novavax 股价早盘上涨 3%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-28 22:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax shares jumped 3% in morning trading.The stock plunged nearly 11% yesterday.</p><p><blockquote>Novavax 股价在早盘交易中上涨 3%。该股昨天暴跌近11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d7f50d71385e7262972c51f222a641a6\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150918555","content_text":"Novavax shares jumped 3% in morning trading.The stock plunged nearly 11% yesterday.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698339602,"gmtCreate":1640302478946,"gmtModify":1640302480586,"author":{"id":"3569375896365334","authorId":"3569375896365334","name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569375896365334","authorIdStr":"3569375896365334"},"themes":[],"title":"","htmlText":"Like n comment pls","listText":"Like n comment pls","text":"Like n comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698339602","repostId":"1172289344","repostType":4,"repost":{"id":"1172289344","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640302012,"share":"https://www.laohunote.com/m/news/1172289344?lang=zh_CN&edition=full","pubTime":"2021-12-24 07:26","market":"us","language":"en","title":"How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?<blockquote>辉瑞的口服 COVID-19 药丸能带来多少收入？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172289344","media":"Benzinga Earnings","summary":"Pfizer, Inc. announced Wednesday its oral COVID-19 antiviral pill, Paxlovid, has been authorized for","content":"<p><b>Pfizer, Inc.</b> announced Wednesday its oral COVID-19 antiviral pill, <b>Paxlovid,</b> has been authorized for use by the U.S. Food and Drug Administration.</p><p><blockquote><b>辉瑞公司。</b>周三宣布其口服 COVID-19 抗病毒药物，<b>帕克斯洛维德，</b>已被美国授权使用。食品药品监督管理局。</blockquote></p><p> <b>The Pfizer Analysts:</b>SVB Leerink analyst Geoffrey Porges has a Market Perform rating and a $52 price target for Pfizer.</p><p><blockquote><b>辉瑞分析师：</b>SVB Leerink 分析师 Geoffrey Porges 对辉瑞给予市场表现评级，目标价为 52 美元。</blockquote></p><p> BofA Securities analyst Geoff Meacham maintained a Neutral rating and a $59 price target.</p><p><blockquote>美国银行证券分析师杰夫·米查姆维持中性评级，目标价为 59 美元。</blockquote></p><p> <b>Broad Label, Increased Supply To Give Pfizer Dominant Market Position:</b>Pfizer received the nod for the oral COVID-19 treatment ahead of <b>Merck & Co., Inc.</b>, which submitted its application for itsmolnupiravirmore than a month ahead of Pfizer, Porges said in a note.</p><p><blockquote><b>广泛的标签，增加供应，使辉瑞占据市场主导地位：</b>辉瑞提前获得口服 COVID-19 治疗的批准<b>默克公司。</b>波吉斯在一份报告中表示，该公司比辉瑞早一个多月提交了莫努匹拉韦的申请。</blockquote></p><p> The analyst sees the increase in Pfizer's expected supply of Paxlovid to 120 million courses next year as significant. The company will sell and distribute most of these courses, resulting in revenue well in excess of SVB Leerink's current forecast of $24 billion in Paxlovid sales in 2022 and $33 billion in 2023, the analyst said.</p><p><blockquote>该分析师认为辉瑞明年 Paxlovid 的预期供应量将增加到 1.2 亿个疗程，意义重大。分析师表示，该公司将销售和分销其中大部分课程，其收入远远超过 SVB Leerink 目前预测的 2022 年 Paxlovid 销售额为 240 亿美元，2023 年为 330 亿美元。</blockquote></p><p> Revenue contribution will drop to $10 billion in 2024, the analyst said. This total $67 billion in Paxlovid sales estimated for 2022-'24 is well above consensus, he added.</p><p><blockquote>分析师表示，2024 年收入贡献将降至 100 亿美元。他补充说，预计 2022-24 年 Paxlovid 的总销售额为 670 亿美元，远高于共识。</blockquote></p><p> The impact of drug-drug interactions on Paxlovid uptake will be modest since many of the drugs on the list can be paused for the short duration of Paxlovid treatment without significant impact for patients, Porges said. Patients that will likely be excluded from Paxlovid use are those with severe liver or renal impairment and those who have uncontrolled HIV-1 infection, he added.</p><p><blockquote>Porges说，药物相互作用对Paxlovid摄取的影响将是适度的，因为清单上的许多药物可以在Paxlovid治疗的短时间内暂停，而不会对患者产生重大影响。他补充说，可能被排除在使用 Paxlovid 之外的患者是那些患有严重肝脏或肾脏损害的患者以及那些患有不受控制的 HIV-1 感染的患者。</blockquote></p><p> The drug label also didn't preclude pregnant women from Paxlovid treatment and painted a risk/benefit profile that was relatively benign compared to Merck's molnupiravir, which showed embryonic development and fetal growth risks in animals, the analyst said.</p><p><blockquote>分析师表示，该药物标签也没有排除孕妇接受Paxlovid治疗，并描绘了与默克公司的molnupiravir相比相对良性的风险/效益概况，后者在动物中显示出胚胎发育和胎儿生长风险。</blockquote></p><p> Paxlovid has a better efficacy profile than some leading antibody therapies, and with some of the antibody therapies having lost efficacy against the omicron variant, Paxlovid will be a \"highly attractive option for physicians and patients,\" Porges said.</p><p><blockquote>Paxlovid 比一些领先的抗体疗法具有更好的疗效，而且由于一些抗体疗法对奥密克戎变异株失去了疗效，Paxlovid 将成为“对医生和患者极具吸引力的选择”，Porges 说。</blockquote></p><p> <b>Paxlovid Should Remain A Steady Contributor, BofA Says:</b>There should be no problem selling every course of Paxlovid Pfizer makes in 2022, BofA analyst Meacham said. The lag time between production and shipping/revenue recognition means Pfizer won't recognize the revenue from every dose in 2022, he added.</p><p><blockquote><b>美国银行表示，Paxlovid 应该仍然是一个稳定的贡献者：</b>美国银行分析师米查姆表示，2022 年销售辉瑞生产的每个疗程的 Paxlovid 应该没有问题。他补充说，生产和运输/收入确认之间的滞后时间意味着辉瑞不会在 2022 年确认每剂疫苗的收入。</blockquote></p><p> Longer-term, Paxlovid is likely to remain a steady contributor, the analyst said.</p><p><blockquote>分析师表示，从长远来看，Paxlovid 可能会保持稳定的贡献者。</blockquote></p><p> \"We expect breakthrough infections to continue regularly in the endemic phase, and while a baseline level of immunity from vaccines and prior infections will limit severity, we expect treatment of COVID cases as they occur in high-risk individuals to be standard of care,\" Meacham said.</p><p><blockquote>“我们预计突破性感染将在地方病阶段继续定期发生，虽然疫苗和既往感染的基线免疫水平将限制严重程度，但我们预计高危个体中发生的新冠病例的治疗将是标准护理，”米查姆说。</blockquote></p><p> Government entities are expected to stockpile Merck's pill and so initial sales will likely be there, the analyst said. Longer-term, Paxlovid will likely be the preferred agent, he added.</p><p><blockquote>这位分析师表示，预计政府机构将储备默克的药丸，因此可能会进行初步销售。他补充说，从长远来看，Paxlovid 可能是首选药物。</blockquote></p><p> <b>Pfizer Price Action:</b> Pfizer shares closed lower 1.41% to $58.71 on Thursday.</p><p><blockquote><b>辉瑞价格走势：</b>辉瑞股价周四收盘下跌 1.41%，至 58.71 美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?<blockquote>辉瑞的口服 COVID-19 药丸能带来多少收入？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?<blockquote>辉瑞的口服 COVID-19 药丸能带来多少收入？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2021-12-24 07:26</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>Pfizer, Inc.</b> announced Wednesday its oral COVID-19 antiviral pill, <b>Paxlovid,</b> has been authorized for use by the U.S. Food and Drug Administration.</p><p><blockquote><b>辉瑞公司。</b>周三宣布其口服 COVID-19 抗病毒药物，<b>帕克斯洛维德，</b>已被美国授权使用。食品药品监督管理局。</blockquote></p><p> <b>The Pfizer Analysts:</b>SVB Leerink analyst Geoffrey Porges has a Market Perform rating and a $52 price target for Pfizer.</p><p><blockquote><b>辉瑞分析师：</b>SVB Leerink 分析师 Geoffrey Porges 对辉瑞给予市场表现评级，目标价为 52 美元。</blockquote></p><p> BofA Securities analyst Geoff Meacham maintained a Neutral rating and a $59 price target.</p><p><blockquote>美国银行证券分析师杰夫·米查姆维持中性评级，目标价为 59 美元。</blockquote></p><p> <b>Broad Label, Increased Supply To Give Pfizer Dominant Market Position:</b>Pfizer received the nod for the oral COVID-19 treatment ahead of <b>Merck & Co., Inc.</b>, which submitted its application for itsmolnupiravirmore than a month ahead of Pfizer, Porges said in a note.</p><p><blockquote><b>广泛的标签，增加供应，使辉瑞占据市场主导地位：</b>辉瑞提前获得口服 COVID-19 治疗的批准<b>默克公司。</b>波吉斯在一份报告中表示，该公司比辉瑞早一个多月提交了莫努匹拉韦的申请。</blockquote></p><p> The analyst sees the increase in Pfizer's expected supply of Paxlovid to 120 million courses next year as significant. The company will sell and distribute most of these courses, resulting in revenue well in excess of SVB Leerink's current forecast of $24 billion in Paxlovid sales in 2022 and $33 billion in 2023, the analyst said.</p><p><blockquote>该分析师认为辉瑞明年 Paxlovid 的预期供应量将增加到 1.2 亿个疗程，意义重大。分析师表示，该公司将销售和分销其中大部分课程，其收入远远超过 SVB Leerink 目前预测的 2022 年 Paxlovid 销售额为 240 亿美元，2023 年为 330 亿美元。</blockquote></p><p> Revenue contribution will drop to $10 billion in 2024, the analyst said. This total $67 billion in Paxlovid sales estimated for 2022-'24 is well above consensus, he added.</p><p><blockquote>分析师表示，2024 年收入贡献将降至 100 亿美元。他补充说，预计 2022-24 年 Paxlovid 的总销售额为 670 亿美元，远高于共识。</blockquote></p><p> The impact of drug-drug interactions on Paxlovid uptake will be modest since many of the drugs on the list can be paused for the short duration of Paxlovid treatment without significant impact for patients, Porges said. Patients that will likely be excluded from Paxlovid use are those with severe liver or renal impairment and those who have uncontrolled HIV-1 infection, he added.</p><p><blockquote>Porges说，药物相互作用对Paxlovid摄取的影响将是适度的，因为清单上的许多药物可以在Paxlovid治疗的短时间内暂停，而不会对患者产生重大影响。他补充说，可能被排除在使用 Paxlovid 之外的患者是那些患有严重肝脏或肾脏损害的患者以及那些患有不受控制的 HIV-1 感染的患者。</blockquote></p><p> The drug label also didn't preclude pregnant women from Paxlovid treatment and painted a risk/benefit profile that was relatively benign compared to Merck's molnupiravir, which showed embryonic development and fetal growth risks in animals, the analyst said.</p><p><blockquote>分析师表示，该药物标签也没有排除孕妇接受Paxlovid治疗，并描绘了与默克公司的molnupiravir相比相对良性的风险/效益概况，后者在动物中显示出胚胎发育和胎儿生长风险。</blockquote></p><p> Paxlovid has a better efficacy profile than some leading antibody therapies, and with some of the antibody therapies having lost efficacy against the omicron variant, Paxlovid will be a \"highly attractive option for physicians and patients,\" Porges said.</p><p><blockquote>Paxlovid 比一些领先的抗体疗法具有更好的疗效，而且由于一些抗体疗法对奥密克戎变异株失去了疗效，Paxlovid 将成为“对医生和患者极具吸引力的选择”，Porges 说。</blockquote></p><p> <b>Paxlovid Should Remain A Steady Contributor, BofA Says:</b>There should be no problem selling every course of Paxlovid Pfizer makes in 2022, BofA analyst Meacham said. The lag time between production and shipping/revenue recognition means Pfizer won't recognize the revenue from every dose in 2022, he added.</p><p><blockquote><b>美国银行表示，Paxlovid 应该仍然是一个稳定的贡献者：</b>美国银行分析师米查姆表示，2022 年销售辉瑞生产的每个疗程的 Paxlovid 应该没有问题。他补充说，生产和运输/收入确认之间的滞后时间意味着辉瑞不会在 2022 年确认每剂疫苗的收入。</blockquote></p><p> Longer-term, Paxlovid is likely to remain a steady contributor, the analyst said.</p><p><blockquote>分析师表示，从长远来看，Paxlovid 可能会保持稳定的贡献者。</blockquote></p><p> \"We expect breakthrough infections to continue regularly in the endemic phase, and while a baseline level of immunity from vaccines and prior infections will limit severity, we expect treatment of COVID cases as they occur in high-risk individuals to be standard of care,\" Meacham said.</p><p><blockquote>“我们预计突破性感染将在地方病阶段继续定期发生，虽然疫苗和既往感染的基线免疫水平将限制严重程度，但我们预计高危个体中发生的新冠病例的治疗将是标准护理，”米查姆说。</blockquote></p><p> Government entities are expected to stockpile Merck's pill and so initial sales will likely be there, the analyst said. Longer-term, Paxlovid will likely be the preferred agent, he added.</p><p><blockquote>这位分析师表示，预计政府机构将储备默克的药丸，因此可能会进行初步销售。他补充说，从长远来看，Paxlovid 可能是首选药物。</blockquote></p><p> <b>Pfizer Price Action:</b> Pfizer shares closed lower 1.41% to $58.71 on Thursday.</p><p><blockquote><b>辉瑞价格走势：</b>辉瑞股价周四收盘下跌 1.41%，至 58.71 美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172289344","content_text":"Pfizer, Inc. announced Wednesday its oral COVID-19 antiviral pill, Paxlovid, has been authorized for use by the U.S. Food and Drug Administration.\nThe Pfizer Analysts:SVB Leerink analyst Geoffrey Porges has a Market Perform rating and a $52 price target for Pfizer.\nBofA Securities analyst Geoff Meacham maintained a Neutral rating and a $59 price target.\nBroad Label, Increased Supply To Give Pfizer Dominant Market Position:Pfizer received the nod for the oral COVID-19 treatment ahead of Merck & Co., Inc., which submitted its application for itsmolnupiravirmore than a month ahead of Pfizer, Porges said in a note.\nThe analyst sees the increase in Pfizer's expected supply of Paxlovid to 120 million courses next year as significant. The company will sell and distribute most of these courses, resulting in revenue well in excess of SVB Leerink's current forecast of $24 billion in Paxlovid sales in 2022 and $33 billion in 2023, the analyst said.\nRevenue contribution will drop to $10 billion in 2024, the analyst said. This total $67 billion in Paxlovid sales estimated for 2022-'24 is well above consensus, he added.\nThe impact of drug-drug interactions on Paxlovid uptake will be modest since many of the drugs on the list can be paused for the short duration of Paxlovid treatment without significant impact for patients, Porges said. Patients that will likely be excluded from Paxlovid use are those with severe liver or renal impairment and those who have uncontrolled HIV-1 infection, he added.\nThe drug label also didn't preclude pregnant women from Paxlovid treatment and painted a risk/benefit profile that was relatively benign compared to Merck's molnupiravir, which showed embryonic development and fetal growth risks in animals, the analyst said.\nPaxlovid has a better efficacy profile than some leading antibody therapies, and with some of the antibody therapies having lost efficacy against the omicron variant, Paxlovid will be a \"highly attractive option for physicians and patients,\" Porges said.\nPaxlovid Should Remain A Steady Contributor, BofA Says:There should be no problem selling every course of Paxlovid Pfizer makes in 2022, BofA analyst Meacham said. The lag time between production and shipping/revenue recognition means Pfizer won't recognize the revenue from every dose in 2022, he added.\nLonger-term, Paxlovid is likely to remain a steady contributor, the analyst said.\n\"We expect breakthrough infections to continue regularly in the endemic phase, and while a baseline level of immunity from vaccines and prior infections will limit severity, we expect treatment of COVID cases as they occur in high-risk individuals to be standard of care,\" Meacham said.\nGovernment entities are expected to stockpile Merck's pill and so initial sales will likely be there, the analyst said. Longer-term, Paxlovid will likely be the preferred agent, he added.\nPfizer Price Action: Pfizer shares closed lower 1.41% to $58.71 on Thursday.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":3095,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691716023,"gmtCreate":1640242845790,"gmtModify":1640242846200,"author":{"id":"3569375896365334","authorId":"3569375896365334","name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569375896365334","authorIdStr":"3569375896365334"},"themes":[],"title":"","htmlText":"Like n comment ","listText":"Like n comment ","text":"Like n comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691716023","repostId":"2193118401","repostType":4,"isVote":1,"tweetType":1,"viewCount":3360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691053623,"gmtCreate":1640100826869,"gmtModify":1640100827266,"author":{"id":"3569375896365334","authorId":"3569375896365334","name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569375896365334","authorIdStr":"3569375896365334"},"themes":[],"title":"","htmlText":"Comment ","listText":"Comment ","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691053623","repostId":"1131687838","repostType":4,"isVote":1,"tweetType":1,"viewCount":3933,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691022473,"gmtCreate":1640100368531,"gmtModify":1640100368982,"author":{"id":"3569375896365334","authorId":"3569375896365334","name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569375896365334","authorIdStr":"3569375896365334"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691022473","repostId":"1148529089","repostType":4,"repost":{"id":"1148529089","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640098401,"share":"https://www.laohunote.com/m/news/1148529089?lang=zh_CN&edition=full","pubTime":"2021-12-21 22:53","market":"us","language":"en","title":"Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.<blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1148529089","media":"Tiger Newspress","summary":"Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.\nPfizer","content":"<p>Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.</p><p><blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote></p><p> Pfizer fell more than 5%, Novavax fell nearly 10%.<img src=\"https://static.tigerbbs.com/8965c7ba2ab9d4149e37dd1a91113e13\" tg-width=\"717\" tg-height=\"600\" width=\"100%\" height=\"auto\"></p><p><blockquote>辉瑞跌幅超过5%，Novavax跌近10%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.<blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.<blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-21 22:53</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.</p><p><blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote></p><p> Pfizer fell more than 5%, Novavax fell nearly 10%.<img src=\"https://static.tigerbbs.com/8965c7ba2ab9d4149e37dd1a91113e13\" tg-width=\"717\" tg-height=\"600\" width=\"100%\" height=\"auto\"></p><p><blockquote>辉瑞跌幅超过5%，Novavax跌近10%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148529089","content_text":"Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.\nPfizer fell more than 5%, Novavax fell nearly 10%.","news_type":1,"symbols_score_info":{"VIR":0.9,"PFE":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3836,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693659087,"gmtCreate":1640015694712,"gmtModify":1640015695097,"author":{"id":"3569375896365334","authorId":"3569375896365334","name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569375896365334","authorIdStr":"3569375896365334"},"themes":[],"title":"","htmlText":"Like n comment pls","listText":"Like n comment pls","text":"Like n comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693659087","repostId":"2192901606","repostType":2,"isVote":1,"tweetType":1,"viewCount":3480,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602345926,"gmtCreate":1638976350670,"gmtModify":1638976381530,"author":{"id":"3569375896365334","authorId":"3569375896365334","name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569375896365334","authorIdStr":"3569375896365334"},"themes":[],"title":"","htmlText":"Comment n like pls","listText":"Comment n like pls","text":"Comment n like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602345926","repostId":"1151922226","repostType":2,"repost":{"id":"1151922226","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638970132,"share":"https://www.laohunote.com/m/news/1151922226?lang=zh_CN&edition=full","pubTime":"2021-12-08 21:28","market":"us","language":"en","title":"New Street Research raised Tesla's target price to $1580, the highest price on Wall Street<blockquote>新街研究将特斯拉目标价上调至1580美元，为华尔街最高价</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1151922226","media":"Tiger Newspress","summary":"Tesla shares changed from decline to rise in premarket trading after New Street Research raised Tesl","content":"<p>Tesla shares changed from decline to rise in premarket trading after New Street Research raised Tesla's target price to $1580, the highest price on Wall Street.</p><p><blockquote>在 New Street Research 将特斯拉目标价上调至华尔街最高价 1580 美元后，特斯拉股价在盘前交易中由跌转涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1f80f033625e9027d5042d14fb5202da\" tg-width=\"851\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> New Street Research boosts its price target on Tesla to $1,580 to mark a new Street high.</p><p><blockquote>New Street Research 将特斯拉的目标价上调至 1,580 美元，创下新高。</blockquote></p><p> Analyst Pierre Ferragu and team point to multiple strong catalysts for Tesla in looking ahead to 2022. Tesla is seen ending this year with an annualized production run-rate of well above 1M units and being likely to deliver a strong Q4 earnings beat. Production out of Berlin and Texas is anticipated to ramp during the year to help the automaker hit 1.5M total deliveries vs. 1.4M consensus and margins are seen cracking the 30% level by the end of the year, despite the ramp of the two factories. Further manufacturing efficiency improvements could help in that regard.</p><p><blockquote>分析师 Pierre Ferragu 和团队指出，展望 2022 年，特斯拉将面临多重强大的催化剂。预计特斯拉今年年底的年化产量将远高于 100 万辆，第四季度盈利可能会强劲增长。柏林和德克萨斯州的产量预计将在今年增加，以帮助该汽车制造商达到 150 万辆总交付量，而市场预期为 140 万辆，尽管这两家工厂的产量有所增加，但到今年年底，利润率预计将突破 30% 的水平。进一步提高制造效率可能会在这方面有所帮助。</blockquote></p><p> Expect to hear more 4680 talk with Tesla in the year ahead. \"We expect 4680 production to be in full swing by year end and grow rapidly from there, and new sites to break ground in order to maintain ~50% annual growth,\" previews Ferragu.</p><p><blockquote>预计未来一年将听到更多 4680 与特斯拉的对话。“我们预计 4680 的生产将在年底全面展开，并从那时起快速增长，新工厂将破土动工，以保持约 50% 的年增长率，”Ferragu 预览道。</blockquote></p><p> New Street Research's price target of $1,580 is based on TSLA trading comfortably at the higher end of the 50X to 100X P/E range. The PT reps right at 50% upside for Tesla from yesterday's closing price and is well in front of the all-time high of $1,243.49.</p><p><blockquote>New Street Research 的目标价为 1,580 美元，这是基于 TSLA 在 50 倍至 100 倍市盈率范围的高端交易。PT 代表特斯拉较昨天收盘价上涨 50%，远远领先于 1,243.49 美元的历史高点。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Street Research raised Tesla's target price to $1580, the highest price on Wall Street<blockquote>新街研究将特斯拉目标价上调至1580美元，为华尔街最高价</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Street Research raised Tesla's target price to $1580, the highest price on Wall Street<blockquote>新街研究将特斯拉目标价上调至1580美元，为华尔街最高价</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-08 21:28</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Tesla shares changed from decline to rise in premarket trading after New Street Research raised Tesla's target price to $1580, the highest price on Wall Street.</p><p><blockquote>在 New Street Research 将特斯拉目标价上调至华尔街最高价 1580 美元后，特斯拉股价在盘前交易中由跌转涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1f80f033625e9027d5042d14fb5202da\" tg-width=\"851\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> New Street Research boosts its price target on Tesla to $1,580 to mark a new Street high.</p><p><blockquote>New Street Research 将特斯拉的目标价上调至 1,580 美元，创下新高。</blockquote></p><p> Analyst Pierre Ferragu and team point to multiple strong catalysts for Tesla in looking ahead to 2022. Tesla is seen ending this year with an annualized production run-rate of well above 1M units and being likely to deliver a strong Q4 earnings beat. Production out of Berlin and Texas is anticipated to ramp during the year to help the automaker hit 1.5M total deliveries vs. 1.4M consensus and margins are seen cracking the 30% level by the end of the year, despite the ramp of the two factories. Further manufacturing efficiency improvements could help in that regard.</p><p><blockquote>分析师 Pierre Ferragu 和团队指出，展望 2022 年，特斯拉将面临多重强大的催化剂。预计特斯拉今年年底的年化产量将远高于 100 万辆，第四季度盈利可能会强劲增长。柏林和德克萨斯州的产量预计将在今年增加，以帮助该汽车制造商达到 150 万辆总交付量，而市场预期为 140 万辆，尽管这两家工厂的产量有所增加，但到今年年底，利润率预计将突破 30% 的水平。进一步提高制造效率可能会在这方面有所帮助。</blockquote></p><p> Expect to hear more 4680 talk with Tesla in the year ahead. \"We expect 4680 production to be in full swing by year end and grow rapidly from there, and new sites to break ground in order to maintain ~50% annual growth,\" previews Ferragu.</p><p><blockquote>预计未来一年将听到更多 4680 与特斯拉的对话。“我们预计 4680 的生产将在年底全面展开，并从那时起快速增长，新工厂将破土动工，以保持约 50% 的年增长率，”Ferragu 预览道。</blockquote></p><p> New Street Research's price target of $1,580 is based on TSLA trading comfortably at the higher end of the 50X to 100X P/E range. The PT reps right at 50% upside for Tesla from yesterday's closing price and is well in front of the all-time high of $1,243.49.</p><p><blockquote>New Street Research 的目标价为 1,580 美元，这是基于 TSLA 在 50 倍至 100 倍市盈率范围的高端交易。PT 代表特斯拉较昨天收盘价上涨 50%，远远领先于 1,243.49 美元的历史高点。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151922226","content_text":"Tesla shares changed from decline to rise in premarket trading after New Street Research raised Tesla's target price to $1580, the highest price on Wall Street.\n\nNew Street Research boosts its price target on Tesla to $1,580 to mark a new Street high.\nAnalyst Pierre Ferragu and team point to multiple strong catalysts for Tesla in looking ahead to 2022. Tesla is seen ending this year with an annualized production run-rate of well above 1M units and being likely to deliver a strong Q4 earnings beat. Production out of Berlin and Texas is anticipated to ramp during the year to help the automaker hit 1.5M total deliveries vs. 1.4M consensus and margins are seen cracking the 30% level by the end of the year, despite the ramp of the two factories. Further manufacturing efficiency improvements could help in that regard.\nExpect to hear more 4680 talk with Tesla in the year ahead. \"We expect 4680 production to be in full swing by year end and grow rapidly from there, and new sites to break ground in order to maintain ~50% annual growth,\" previews Ferragu.\nNew Street Research's price target of $1,580 is based on TSLA trading comfortably at the higher end of the 50X to 100X P/E range. The PT reps right at 50% upside for Tesla from yesterday's closing price and is well in front of the all-time high of $1,243.49.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":3580,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602342522,"gmtCreate":1638976330496,"gmtModify":1638976330817,"author":{"id":"3569375896365334","authorId":"3569375896365334","name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569375896365334","authorIdStr":"3569375896365334"},"themes":[],"title":"","htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602342522","repostId":"1151922226","repostType":2,"repost":{"id":"1151922226","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638970132,"share":"https://www.laohunote.com/m/news/1151922226?lang=zh_CN&edition=full","pubTime":"2021-12-08 21:28","market":"us","language":"en","title":"New Street Research raised Tesla's target price to $1580, the highest price on Wall Street<blockquote>新街研究将特斯拉目标价上调至1580美元，为华尔街最高价</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1151922226","media":"Tiger Newspress","summary":"Tesla shares changed from decline to rise in premarket trading after New Street Research raised Tesl","content":"<p>Tesla shares changed from decline to rise in premarket trading after New Street Research raised Tesla's target price to $1580, the highest price on Wall Street.</p><p><blockquote>在 New Street Research 将特斯拉目标价上调至华尔街最高价 1580 美元后，特斯拉股价在盘前交易中由跌转涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1f80f033625e9027d5042d14fb5202da\" tg-width=\"851\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> New Street Research boosts its price target on Tesla to $1,580 to mark a new Street high.</p><p><blockquote>New Street Research 将特斯拉的目标价上调至 1,580 美元，创下新高。</blockquote></p><p> Analyst Pierre Ferragu and team point to multiple strong catalysts for Tesla in looking ahead to 2022. Tesla is seen ending this year with an annualized production run-rate of well above 1M units and being likely to deliver a strong Q4 earnings beat. Production out of Berlin and Texas is anticipated to ramp during the year to help the automaker hit 1.5M total deliveries vs. 1.4M consensus and margins are seen cracking the 30% level by the end of the year, despite the ramp of the two factories. Further manufacturing efficiency improvements could help in that regard.</p><p><blockquote>分析师 Pierre Ferragu 和团队指出，展望 2022 年，特斯拉将面临多重强大的催化剂。预计特斯拉今年年底的年化产量将远高于 100 万辆，第四季度盈利可能会强劲增长。柏林和德克萨斯州的产量预计将在今年增加，以帮助该汽车制造商达到 150 万辆总交付量，而市场预期为 140 万辆，尽管这两家工厂的产量有所增加，但到今年年底，利润率预计将突破 30% 的水平。进一步提高制造效率可能会在这方面有所帮助。</blockquote></p><p> Expect to hear more 4680 talk with Tesla in the year ahead. \"We expect 4680 production to be in full swing by year end and grow rapidly from there, and new sites to break ground in order to maintain ~50% annual growth,\" previews Ferragu.</p><p><blockquote>预计未来一年将听到更多 4680 与特斯拉的对话。“我们预计 4680 的生产将在年底全面展开，并从那时起快速增长，新工厂将破土动工，以保持约 50% 的年增长率，”Ferragu 预览道。</blockquote></p><p> New Street Research's price target of $1,580 is based on TSLA trading comfortably at the higher end of the 50X to 100X P/E range. The PT reps right at 50% upside for Tesla from yesterday's closing price and is well in front of the all-time high of $1,243.49.</p><p><blockquote>New Street Research 的目标价为 1,580 美元，这是基于 TSLA 在 50 倍至 100 倍市盈率范围的高端交易。PT 代表特斯拉较昨天收盘价上涨 50%，远远领先于 1,243.49 美元的历史高点。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Street Research raised Tesla's target price to $1580, the highest price on Wall Street<blockquote>新街研究将特斯拉目标价上调至1580美元，为华尔街最高价</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Street Research raised Tesla's target price to $1580, the highest price on Wall Street<blockquote>新街研究将特斯拉目标价上调至1580美元，为华尔街最高价</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-08 21:28</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Tesla shares changed from decline to rise in premarket trading after New Street Research raised Tesla's target price to $1580, the highest price on Wall Street.</p><p><blockquote>在 New Street Research 将特斯拉目标价上调至华尔街最高价 1580 美元后，特斯拉股价在盘前交易中由跌转涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1f80f033625e9027d5042d14fb5202da\" tg-width=\"851\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> New Street Research boosts its price target on Tesla to $1,580 to mark a new Street high.</p><p><blockquote>New Street Research 将特斯拉的目标价上调至 1,580 美元，创下新高。</blockquote></p><p> Analyst Pierre Ferragu and team point to multiple strong catalysts for Tesla in looking ahead to 2022. Tesla is seen ending this year with an annualized production run-rate of well above 1M units and being likely to deliver a strong Q4 earnings beat. Production out of Berlin and Texas is anticipated to ramp during the year to help the automaker hit 1.5M total deliveries vs. 1.4M consensus and margins are seen cracking the 30% level by the end of the year, despite the ramp of the two factories. Further manufacturing efficiency improvements could help in that regard.</p><p><blockquote>分析师 Pierre Ferragu 和团队指出，展望 2022 年，特斯拉将面临多重强大的催化剂。预计特斯拉今年年底的年化产量将远高于 100 万辆，第四季度盈利可能会强劲增长。柏林和德克萨斯州的产量预计将在今年增加，以帮助该汽车制造商达到 150 万辆总交付量，而市场预期为 140 万辆，尽管这两家工厂的产量有所增加，但到今年年底，利润率预计将突破 30% 的水平。进一步提高制造效率可能会在这方面有所帮助。</blockquote></p><p> Expect to hear more 4680 talk with Tesla in the year ahead. \"We expect 4680 production to be in full swing by year end and grow rapidly from there, and new sites to break ground in order to maintain ~50% annual growth,\" previews Ferragu.</p><p><blockquote>预计未来一年将听到更多 4680 与特斯拉的对话。“我们预计 4680 的生产将在年底全面展开，并从那时起快速增长，新工厂将破土动工，以保持约 50% 的年增长率，”Ferragu 预览道。</blockquote></p><p> New Street Research's price target of $1,580 is based on TSLA trading comfortably at the higher end of the 50X to 100X P/E range. The PT reps right at 50% upside for Tesla from yesterday's closing price and is well in front of the all-time high of $1,243.49.</p><p><blockquote>New Street Research 的目标价为 1,580 美元，这是基于 TSLA 在 50 倍至 100 倍市盈率范围的高端交易。PT 代表特斯拉较昨天收盘价上涨 50%，远远领先于 1,243.49 美元的历史高点。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151922226","content_text":"Tesla shares changed from decline to rise in premarket trading after New Street Research raised Tesla's target price to $1580, the highest price on Wall Street.\n\nNew Street Research boosts its price target on Tesla to $1,580 to mark a new Street high.\nAnalyst Pierre Ferragu and team point to multiple strong catalysts for Tesla in looking ahead to 2022. Tesla is seen ending this year with an annualized production run-rate of well above 1M units and being likely to deliver a strong Q4 earnings beat. Production out of Berlin and Texas is anticipated to ramp during the year to help the automaker hit 1.5M total deliveries vs. 1.4M consensus and margins are seen cracking the 30% level by the end of the year, despite the ramp of the two factories. Further manufacturing efficiency improvements could help in that regard.\nExpect to hear more 4680 talk with Tesla in the year ahead. \"We expect 4680 production to be in full swing by year end and grow rapidly from there, and new sites to break ground in order to maintain ~50% annual growth,\" previews Ferragu.\nNew Street Research's price target of $1,580 is based on TSLA trading comfortably at the higher end of the 50X to 100X P/E range. The PT reps right at 50% upside for Tesla from yesterday's closing price and is well in front of the all-time high of $1,243.49.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":3424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606901497,"gmtCreate":1638804470921,"gmtModify":1638804471245,"author":{"id":"3569375896365334","authorId":"3569375896365334","name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569375896365334","authorIdStr":"3569375896365334"},"themes":[],"title":"","htmlText":"Like n comment pls","listText":"Like n comment pls","text":"Like n comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606901497","repostId":"1117755408","repostType":2,"repost":{"id":"1117755408","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638801900,"share":"https://www.laohunote.com/m/news/1117755408?lang=zh_CN&edition=full","pubTime":"2021-12-06 22:45","market":"us","language":"en","title":"Apple stock surged more than 3% in morning trading<blockquote>苹果股价早盘飙升超过 3%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1117755408","media":"Tiger Newspress","summary":"Apple stock surged more than 3% in morning trading.Apple plans to produce up to 96 million iPhones f","content":"<p>Apple stock surged more than 3% in morning trading.Apple plans to produce up to 96 million iPhones for the first half of 2021, a nearly 30% year-on-year increase, after demand for its first-ever 5G handsets surged amid the pandemic, according to Nikkei Asia.</p><p><blockquote>苹果股价在早盘交易中飙升超过 3%。据日经亚洲报道，在疫情期间对其首款 5G 手机的需求激增后，苹果公司计划在 2021 年上半年生产多达 9600 万部 iPhone，同比增长近 30%。</blockquote></p><p> The Cupertino-based tech giant has asked suppliers to build some 95 million to 96 million iPhones, including the latest iPhone 12 range and the older iPhone 11 and iPhone SE, multiple people familiar with the matter said -- though industrywide shortages of key components could threaten that target.</p><p><blockquote>多位知情人士表示，这家总部位于库比蒂诺的科技巨头已要求供应商生产约 9500 万至 9600 万部 iPhone，包括最新的 iPhone 12 系列以及较旧的 iPhone 11 和 iPhone SE，尽管全行业关键部件短缺可能会威胁到这一目标。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/55a8103513629aeb04b5256e70aa8380\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple stock surged more than 3% in morning trading<blockquote>苹果股价早盘飙升超过 3%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple stock surged more than 3% in morning trading<blockquote>苹果股价早盘飙升超过 3%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 22:45</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Apple stock surged more than 3% in morning trading.Apple plans to produce up to 96 million iPhones for the first half of 2021, a nearly 30% year-on-year increase, after demand for its first-ever 5G handsets surged amid the pandemic, according to Nikkei Asia.</p><p><blockquote>苹果股价在早盘交易中飙升超过 3%。据日经亚洲报道，在疫情期间对其首款 5G 手机的需求激增后，苹果公司计划在 2021 年上半年生产多达 9600 万部 iPhone，同比增长近 30%。</blockquote></p><p> The Cupertino-based tech giant has asked suppliers to build some 95 million to 96 million iPhones, including the latest iPhone 12 range and the older iPhone 11 and iPhone SE, multiple people familiar with the matter said -- though industrywide shortages of key components could threaten that target.</p><p><blockquote>多位知情人士表示，这家总部位于库比蒂诺的科技巨头已要求供应商生产约 9500 万至 9600 万部 iPhone，包括最新的 iPhone 12 系列以及较旧的 iPhone 11 和 iPhone SE，尽管全行业关键部件短缺可能会威胁到这一目标。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/55a8103513629aeb04b5256e70aa8380\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117755408","content_text":"Apple stock surged more than 3% in morning trading.Apple plans to produce up to 96 million iPhones for the first half of 2021, a nearly 30% year-on-year increase, after demand for its first-ever 5G handsets surged amid the pandemic, according to Nikkei Asia.\nThe Cupertino-based tech giant has asked suppliers to build some 95 million to 96 million iPhones, including the latest iPhone 12 range and the older iPhone 11 and iPhone SE, multiple people familiar with the matter said -- though industrywide shortages of key components could threaten that target.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":3355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606909386,"gmtCreate":1638804324058,"gmtModify":1638804324408,"author":{"id":"3569375896365334","authorId":"3569375896365334","name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569375896365334","authorIdStr":"3569375896365334"},"themes":[],"title":"","htmlText":"Comment n like pls","listText":"Comment n like pls","text":"Comment n like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/606909386","repostId":"1167580246","repostType":2,"repost":{"id":"1167580246","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638802452,"share":"https://www.laohunote.com/m/news/1167580246?lang=zh_CN&edition=full","pubTime":"2021-12-06 22:54","market":"us","language":"en","title":"Semiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1167580246","media":"Tiger Newspress","summary":"Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Se","content":"<p>Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Semiconductor fell between 2% and 7%.</p><p><blockquote>半导体股早盘下跌.英伟达、台积电、ASML、AMD、赛灵思、Globalfoundries和安森美半导体下跌2%至7%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fd417bf4091570cb848a432d4946ce4\" tg-width=\"400\" tg-height=\"714\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 22:54</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Semiconductor fell between 2% and 7%.</p><p><blockquote>半导体股早盘下跌.英伟达、台积电、ASML、AMD、赛灵思、Globalfoundries和安森美半导体下跌2%至7%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fd417bf4091570cb848a432d4946ce4\" tg-width=\"400\" tg-height=\"714\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","TSM":"台积电","MRVL":"迈威尔科技","MU":"美光科技","ADI":"亚德诺","ON":"安森美半导体","QCOM":"高通","AMD":"美国超微公司","TXN":"德州仪器","ASML":"阿斯麦","GFS":"GLOBALFOUNDRIES Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167580246","content_text":"Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Semiconductor fell between 2% and 7%.","news_type":1,"symbols_score_info":{"NVDA":0.9,"GFS":0.9,"MU":0.9,"ADI":0.9,"ON":0.9,"TXN":0.9,"TSM":0.9,"QCOM":0.9,"AMD":0.9,"XLNX":0.9,"ASML":0.9,"MRVL":0.9}},"isVote":1,"tweetType":1,"viewCount":3422,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}